Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
May AMH levels distinguish LOCAH from PCOS among hirsute women?
[congenital adrenal hyperplasia]
To
determine
whether
women
with
polycystic
ovary
syndrome
(
PCOS
)
would
be
distinguishable
from
women
with
late
onset
congenital
adrenal
hyperplasia
(
LOCAH
)
on
the
basis
of
antimullerian
hormone
(
AMH
)
levels
.
PCOS
was
diagnosed
in
170
women
;
105
were
polycystic
ovary
morphology
(
PCOM
)
+
/
oligo-anovulation
(
OA
)
+
/
hyperandrogenism
(
HA
)
+
,
40
PCOM
+
/
OA-
/
HA
+
and
25
PCOM-
/
OA
+
/
HA
+
.
These
three
groups
were
compared
with
25
women
in
whom
LOCAH
was
diagnosed
.
The
mean
serum
AMH
levels
were
8
.
12
±
1
.
85
ng
/
ml
in
PCOM
+
/
OA
+
/
HA
+
group
,
5
.
34
±
1
.
82
ng
/
ml
in
PCOM
+
/
OA-
/
HA
+
group
,
3
.
02
±
1
.
76
ng
/
ml
in
PCOM-
/
OA
+
/
HA
+
group
and
4
.
43
±
1
.
29
ng
/
ml
in
LOCAH
group
.
The
mean
AMH
level
in
PCOM
+
/
OA
+
/
HA
+
group
was
approximately
twofold
higher
than
the
mean
AMH
level
measured
in
LOCAH
group
(
p
<
0
.
001
)
.
Women
with
PCOM
+
/
OA-
/
HA
+
had
higher
serum
AMH
levels
than
those
with
LOCAH
,
women
with
LOCAH
had
higher
serum
AMH
levels
than
those
with
PCOM-
/
OA
+
/
HA
+
but
these
differences
were
not
statistically
significant
(
p
>
0
.
05
)
.
AMH
is
not
suitable
for
distinguishing
LOCAH
from
all
types
of
hyperandrogenic
patterns
of
PCOS
,
but
is
only
applicable
for
a
specific
subtype
,
such
as
PCOS
patients
with
three
main
diagnostic
criteria
.
Therefore
,
ACTH
stimulation
test
remains
an
essential
clinical
tool
to
diagnose
LOCAH
.
Diseases
Validation
Diseases presenting
"such as pcos patients with three main diagnostic criteria"
symptom
congenital adrenal hyperplasia
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom